Alkim Alkali Kimya AS
IST:ALKIM.E
Alkim Alkali Kimya AS
IST:ALKIM.E
Price:
18.96
TRY
2.1%
Market Closed
Market Cap:
₺5.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Alkim Alkali Kimya AS
IST:ALKIM.E
|
TR |
|
Narasaki Sangyo Co Ltd
TSE:8085
|
JP |
|
A
|
Aurobindo Pharma Ltd
BSE:524804
|
IN |
|
L
|
Lagercrantz Group AB
LSE:0RB7
|
SE |
|
MTI Ltd
TSE:9438
|
JP |
|
Hoshizaki Corp
TSE:6465
|
JP |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
|
Xiwang Foodstuffs Co Ltd
SZSE:000639
|
CN |
|
Just Dial Ltd
NSE:JUSTDIAL
|
IN |
|
Siemens Energy India Ltd
NSE:ENRIN
|
IN |
|
Embracer Group AB
STO:EMBRAC B
|
SE |
|
Ming Fai International Holdings Ltd
HKEX:3828
|
HK |
|
DLG Exhibitions & Events Corp Ltd
SSE:600826
|
CN |
|
PeptiDream Inc
TSE:4587
|
JP |
|
Biotalys NV
XBRU:BTLS
|
BE |
|
H
|
Harn Len Corporation Bhd
KLSE:HARNLEN
|
MY |
|
G
|
Global Digital Solutions Inc
OTC:GDSI
|
US |
|
S
|
SL Corp
KRX:005850
|
KR |
|
G
|
GG Dandekar Machine Works Ltd
BSE:505250
|
IN |
|
G
|
Groupe Okwind SA
PAR:ALOKW
|
FR |
Balance Sheet
Balance Sheet Decomposition
Alkim Alkali Kimya AS
Alkim Alkali Kimya AS
Balance Sheet Decomposition is not available for
Alkim Alkali Kimya AS
Alkim Alkali Kimya AS
Balance Sheet
Alkim Alkali Kimya AS
Alkim Alkali Kimya AS
Currency: TRY
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
82
|
67
|
90
|
150
|
193
|
336
|
345
|
751
|
612
|
271
|
|
| Cash |
3
|
0
|
3
|
8
|
12
|
50
|
70
|
53
|
75
|
239
|
|
| Cash Equivalents |
79
|
67
|
88
|
142
|
182
|
285
|
275
|
698
|
538
|
32
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
256
|
0
|
0
|
|
| Total Receivables |
55
|
54
|
73
|
103
|
142
|
239
|
832
|
603
|
852
|
845
|
|
| Accounts Receivables |
46
|
49
|
6
|
12
|
24
|
238
|
801
|
572
|
611
|
753
|
|
| Other Receivables |
9
|
5
|
67
|
90
|
117
|
2
|
31
|
31
|
241
|
93
|
|
| Inventory |
58
|
79
|
121
|
109
|
160
|
258
|
996
|
1 155
|
1 377
|
1 208
|
|
| Other Current Assets |
12
|
17
|
26
|
20
|
16
|
12
|
86
|
64
|
117
|
195
|
|
| Total Current Assets |
207
|
218
|
311
|
382
|
511
|
846
|
2 304
|
2 853
|
2 981
|
2 519
|
|
| PP&E Net |
131
|
159
|
155
|
151
|
154
|
262
|
1 298
|
1 854
|
3 039
|
3 611
|
|
| PP&E Gross |
131
|
159
|
155
|
151
|
154
|
262
|
1 298
|
1 854
|
3 039
|
3 611
|
|
| Accumulated Depreciation |
191
|
208
|
228
|
249
|
269
|
287
|
3 847
|
5 721
|
7 724
|
7 964
|
|
| Intangible Assets |
1
|
1
|
1
|
3
|
4
|
3
|
10
|
12
|
14
|
12
|
|
| Note Receivable |
0
|
0
|
1
|
1
|
2
|
2
|
5
|
7
|
11
|
13
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
10
|
12
|
11
|
16
|
84
|
38
|
58
|
392
|
326
|
127
|
|
| Total Assets |
349
N/A
|
390
+12%
|
478
+23%
|
553
+16%
|
755
+36%
|
1 150
+52%
|
3 674
+219%
|
5 119
+39%
|
6 371
+24%
|
6 282
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
28
|
28
|
47
|
46
|
64
|
217
|
500
|
753
|
1 009
|
1 111
|
|
| Accrued Liabilities |
3
|
3
|
4
|
5
|
6
|
9
|
27
|
49
|
61
|
67
|
|
| Short-Term Debt |
35
|
26
|
26
|
36
|
0
|
0
|
0
|
55
|
0
|
107
|
|
| Current Portion of Long-Term Debt |
8
|
12
|
12
|
14
|
2
|
27
|
56
|
79
|
47
|
60
|
|
| Other Current Liabilities |
5
|
6
|
14
|
10
|
72
|
79
|
79
|
144
|
66
|
102
|
|
| Total Current Liabilities |
79
|
75
|
103
|
112
|
144
|
332
|
662
|
1 079
|
1 182
|
1 448
|
|
| Long-Term Debt |
18
|
18
|
12
|
1
|
45
|
49
|
54
|
0
|
122
|
76
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
137
|
0
|
9
|
155
|
|
| Minority Interest |
24
|
26
|
30
|
33
|
42
|
70
|
193
|
262
|
296
|
273
|
|
| Other Liabilities |
7
|
10
|
14
|
17
|
24
|
32
|
102
|
74
|
89
|
76
|
|
| Total Liabilities |
128
N/A
|
128
0%
|
160
+25%
|
163
+2%
|
255
+56%
|
483
+89%
|
1 149
+138%
|
1 415
+23%
|
1 697
+20%
|
2 028
+19%
|
|
| Equity | |||||||||||
| Common Stock |
25
|
25
|
25
|
25
|
150
|
150
|
150
|
150
|
300
|
300
|
|
| Retained Earnings |
172
|
215
|
273
|
347
|
362
|
531
|
2 407
|
3 636
|
4 477
|
4 069
|
|
| Other Equity |
24
|
22
|
21
|
18
|
13
|
14
|
32
|
82
|
104
|
115
|
|
| Total Equity |
221
N/A
|
262
+18%
|
318
+22%
|
390
+22%
|
499
+28%
|
667
+34%
|
2 525
+278%
|
3 704
+47%
|
4 673
+26%
|
4 254
-9%
|
|
| Total Liabilities & Equity |
349
N/A
|
390
+12%
|
478
+23%
|
553
+16%
|
755
+36%
|
1 150
+52%
|
3 674
+219%
|
5 119
+39%
|
6 371
+24%
|
6 282
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
300
|
300
|
300
|
300
|
300
|
300
|
300
|
300
|
150
|
300
|
|
Switch to:
Switch to:
See Also
Discover More
